BeOne Medicines (BEIGF) EPS (Diluted) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EPS (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | -3.06 |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 7.27 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 2.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 |
| Mar 31, 2026 | 1.96 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 1.09 |
| Jun 30, 2025 | 0.84 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | -1.44 |
| Sep 30, 2024 | -1.15 |
| Jun 30, 2024 | -1.15 |
| Mar 31, 2024 | -2.41 |
| Dec 31, 2023 | -3.52 |
| Sep 30, 2023 | 2.01 |
| Jun 30, 2023 | -3.64 |
| Mar 31, 2023 | -3.34 |
| Dec 31, 2022 | -4.32 |
| Sep 30, 2022 | -5.39 |
| Jun 30, 2022 | -5.50 |
| Mar 31, 2022 | -4.25 |
| Dec 31, 2021 | -6.37 |
| Sep 30, 2021 | -4.72 |